To analyze the resistant mechanism of GIST-IR cells against imatinib, we investigated differences in protein kinase activations between GIST-IR cells before and after treatment with imatinib, using a RTK phosphorylation array (Supplementary Figure 1). Here, WEE1 is linked to gastrointestinal stromal tumor.